Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
Oncogene
|
August 4, 2015
TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis
F Macari, Y El-Houfi, G Boldina, et al.
British Journal of Cancer
|
June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium
V Launonen, K Laake, P Huusko, et al.
Genes, Chromosomes & Cancer
|
June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium
K Laake, V Launonen, D Niederacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
M Beau-Faller, N Prim, A-M Ruppert, et al.
British Journal of Cancer
|
April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
C Le Tourneau, X Paoletti, N Servant, et al.
ESMO Open
|
April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
E de Guillebon, M Jimenez, L Mazzarella, et al.
ESMO Open
|
December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas
D M Filippini, B Cabarrou, C Dupain, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
K Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2024
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M F Mosele, C B Westphalen, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, et al.
Oncogene
|
August 4, 2015
TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis
F Macari, Y El-Houfi, G Boldina, et al.
British Journal of Cancer
|
June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium
V Launonen, K Laake, P Huusko, et al.
Genes, Chromosomes & Cancer
|
June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium
K Laake, V Launonen, D Niederacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
M Beau-Faller, N Prim, A-M Ruppert, et al.
British Journal of Cancer
|
April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
C Le Tourneau, X Paoletti, N Servant, et al.
ESMO Open
|
April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
E de Guillebon, M Jimenez, L Mazzarella, et al.
ESMO Open
|
December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas
D M Filippini, B Cabarrou, C Dupain, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
K Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Page
of 10